Inflammatory Bowel Diseases PDF

Loading...
Loading...
Loading...
Loading...
Loading...
Loading...
Loading...

Summary

This document provides information on inflammatory bowel diseases, specifically Crohn's disease and ulcerative colitis. It covers general considerations, symptoms, physical examination, laboratory values, special diagnostic studies, complications, and treatment of active disease.

Full Transcript

# Inflammatory bowel diseases ## Crohn's Disease ### GENERAL CONSIDERATIONS - 30% of cases involve the small bowel only mostly (ileitis). - 50% of all cases involve the small bowel and colon (ileococolitis). - In 20% of cases, the colon alone is affected. - 30% of patients have associated perianal d...

# Inflammatory bowel diseases ## Crohn's Disease ### GENERAL CONSIDERATIONS - 30% of cases involve the small bowel only mostly (ileitis). - 50% of all cases involve the small bowel and colon (ileococolitis). - In 20% of cases, the colon alone is affected. - 30% of patients have associated perianal disease. - Less than 5% of patients have symptomatic involvement of the upper intestinal tract. - Crohn's disease is a transmural process that can result in mucosal inflammation and ulceration, stricturing, fistula development, and abscess formation. - Cigarette smoking is strongly associated with the development of Crohn's disease, resistance to medical therapy, and early disease relapse. ## Symptoms and Signs - Malaise, weight loss, and loss of energy. - In patients with ileitis or ileocalitis, there may be diarrhea (usually) non bloody and intermittent. - In patients with colitis involving the rectum or left colon, there may be bloody diarrhea and fecal urgency, which may mimic the symptoms of ulcerative colitis. - Cramping or steady right lower quadrant or periumbilical pain is common. ## Physical examination - Focal tenderness, usually in the right lower quadrant. - Apalpable, tender mass that represents thickened or matted loops of inflamed intestine in the lower abdomen. - Intestinal obstruction due to narrowing of the small bowel may occur as a result of inflammation, spasm, or fibrotic stenosis. - Penetrating disease and fistulae: Penetration through the bowel can result in an intra-abdominal or retroperitoneal phlegmon or abscess manifested by: - Fevers, chills, a tender abdominal mass, and leukocytosis. ## Extraintestinal manifestations: - Arthralgias, arthritis. - Iritis or uveitis. - Pyoderma gangrenosum or erythema nodosum. - Oral aphthous lesions are common. - Gallstones. - Nephrolithiasis with urate or calcium oxalate stones may occur. ## Laboratory values - CBC: Anemia (Iron deficiency or vitamin B12 Malabsorption) and Leukocytosis - Hypoalbuminemia - ↑↑ ESR or C-reactive protein - Fecal lactoferrin or calprotectin levels. - Stool specimens are sent for examination for routine pathogens, ova and parasites, leukocytes, fat, and C difficile toxin. ## Special Diagnostic Studies: - Colonoscopy. - CT or MR Enterography or small bowel follow-through. - Capsule endoscopy. ## COMPLICATIONS - Abscess - Obstruction - Abdominal and Rectovaginal Fistulas - Carcinoma - Hemorrhage - Malabsorption ## TREATMENT OF ACTIVE DISEASE ### A. Nutrition #### 1. Diet: - Patients should eat a well-balanced diet with as few restrictions as possible. - Eating smaller but more frequent meals. - Patients with diarrhea (drink fluids to avoid dehydration). - Certain foods worsen symptoms, especially fried or greasy foods, because lactose intolerance is common. - Patients with obstructive symptoms should be placed on a low-roughage diet, ie, no raw fruits or vegetables, popcorn, nuts, etc. - Resection of more than 100 cm of terminal ileum results in fat malabsorption for which a low-fat diet is recommended. - Parenteral vitamin B12 (100 mcg intramuscularly per month) commonly is needed for patients with previous ileal resection or extensive terminal ileal disease. #### 2. Enteral therapy: - Supplemental enteral therapy via nasogastric tube may be required for children and adolescents with poor intake and growth retardation. #### 3. Total parenteral nutrition: - TPN is used short term in patients with active disease and progressive weight loss or those awaiting surgery. # Ulcerative Colitis ## ESSENTIALS OF DIAGNOSIS - Bloody diarrhea. - Lower abdominal cramps and fecal urgency. - Anemia, low serum albumin. - Negative stool cultures. - Sigmoidoscopy is the key to diagnosis. ## CLINICAL FINDINGS ### 1. Symptoms and Signs - Bloody diarrhea is the hallmark (patients should be asked about stool frequency, the presence and amount of rectal bleeding). - Lower abdominal cramps, tenesmus and fecal urgency. ### A. Physical examination - Should focus on the patient's volume status as determined by orthostatic blood pressure and pulse measurements and by nutritional status. - On abdominal examination, the clinician should look for tenderness and evidence of peritoneal inflammation. - Red blood may be present on digital rectal examination. ### B. Laboratory Findings - The degree of anemia, sedimentation rate, and serum albumin reflects disease severity. ### C. Endoscopy #### 1. DISEASE SEVERITY - Patients with mild disease - Have a gradual onset of infrequent diarrhea (less than four movements per day) with intermittent rectal bleeding and mucus. - Stools may be formed or loose in consistency. - Because of rectal inflammation, there is fecal urgency and tenesmus. - Left lower quadrant cramps relieved by defecation are common, but there is no significant abdominal tenderness. #### 2. Patients with moderate disease - Have more severe diarrhea with frequent bleeding. - Abdominal pain and tenderness may be present but are not severe. - There may be mild fever, anemia, and hypoalbuminemia. #### 3. Severe disease - Patients with severe disease have more than six bloody bowel movements per day, resulting in severe anemia, hypovolemia, and impaired nutrition with hypoalbuminemia. - Abdominal pain and tenderness are present. - "Fulminant colitis" is a subset of severe disease characterized by rapidly worsening symptoms with signs of toxicity, ## General measures: - Discontinue all oral intake for 24-48 hours or until the patient demonstrates clinical improvement. - TPN is indicated only in patients with poor nutritional status or if feedings cannot be reinstituted within 7-10 days. - All opioid or anticholinergic agents should be discontinued. - Restore circulating volume with fluids, correct electrolyte abnormalities, and consider transfusion for significant anemia. - Abdominal examinations should be repeated to look for evidence of worsening distention or pain. - A plain abdominal radiograph should be ordered on admission to look for evidence of colonic dilation. - Send stools for bacterial culture, *C difficile* toxin assay, and examination for ova and parasites. - CMV superinfection should be considered in patients receiving long-term immunosuppressive therapy who are unresponsive to corticosteroid therapy. - Due to a high risk of venous thromboembolic disease, prophylaxis should be administered. - Surgical consultation should be sought for all patients with severe disease. ## 1- Corticosteroid therapy: ## 2- Anti-TNF therapies: - A single infusion of infliximab, 5 mg/kg ## 3- Cyclosporine: ## 4- Surgical therapy: - Patients with severe disease who do not improve after corticosteroid, infliximab, or cyclosporine ## COMPLICATIONS: - Endoscopic or histologic inflammation in the ileal pouch ("pouchitis") develops in over 40% of patients, resulting in increased stool frequency, fecal urgency, cramping, and bleeding.

Use Quizgecko on...
Browser
Browser